This compound is a zinc salt pharmaceutical intermediate, specifically this compound. It is used in the manufacturing of pharmaceutical compounds as a chemical building block.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2245111-19-5
Deucravacitinib
pharmaceutical raw material
Lithium 4,6-Dichloropyridazine-3-carboxylate
pharmaceutical intermediate
(2-Amino-5-nitrophenyl)(2-chlorophenyl)methanone Phthalimido
pharmaceutical intermediate
(2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methanol hydrochloride
pharmaceutical intermediate
4-Amino-3-fluoropyridine
pharmaceutical intermediate
6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic acid
pharmaceutical intermediate
zinc bis(6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]pyridazine-3-carboxylate)
UMUQEYKVUKQYDI-UHFFFAOYSA-L
CN1C=NC(=N1)C2=C(C(=CC=C2)NC3=CC(=NN=C3C(=O)[O-])NC(=O)C4CC4)OC.CN1C=NC(=N1)C2=C(C(=CC=C2)NC3=CC(=NN=C3C(=O)[O-])NC(=O)C4CC4)OC.[Zn+2]
—